Micrometastases in thyroid cancer. An important finding?

Area of Science:

• Oncology
• Surgical Pathology

Background:

• Differentiated thyroid cancer generally has a good prognosis.
• Lymph node metastases in differentiated thyroid cancer correlate with higher loco-regional recurrence rates and potentially decreased survival.
• Current guidelines suggest routine central node dissection and increased interest in lateral compartment sampling and sentinel node biopsy.

Purpose of the Study:

• To review the evidence regarding the clinical significance of micrometastatic disease in differentiated thyroid cancer.
• To evaluate whether aggressive surgical intervention for micrometastatic disease is warranted.

Main Methods:

• Literature review of studies examining lymph node metastases in differentiated thyroid cancer.
• Analysis of recurrence rates in regions with and without routine lymph node dissection.
• Assessment of the impact of micrometastatic disease on prognosis and treatment outcomes.

Main Results:

• The majority of differentiated thyroid cancer cases exhibit lymph node metastases, often micrometastatic.
• Regions not performing routine lymph node dissection show relatively low recurrence rates.
• Evidence suggests that not all micrometastatic disease progresses to loco-regional recurrence, or it is effectively managed by adjuvant radioactive iodine.

Conclusions:

• Micrometastatic differentiated thyroid cancer is likely of minimal clinical significance.
• Aggressive surgical intervention for micrometastatic disease is probably not warranted.
• A conservative surgical approach combined with adjuvant radioactive iodine is expected to achieve durable disease control.